WEALTHFRONT CORP
For the period ended Jul 31, 2026. Filed Sep 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2026 · Filed Sep 14, 2026
WLTH$10.93-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Six Months Ended July 31, | ||
|---|---|---|
| (in thousands) | 2026 | 2025 |
| Operating activities | ||
| Net income | $30,585 | $60,688 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization of property, software, and equipment, net | 2,671 | 3,706 |
| Non-cash lease expense | 1,615 | 1,608 |
| Deferred income taxes | 5,828 | 9,727 |
| Stock-based compensation expense | 33,485 | 3,450 |
| Impairment of internally developed software | — | 709 |
| Change in fair value of warrant liabilities | 157 | 414 |
| Change in fair value of simple agreement for future equity | — | 945 |
| Changes in operating assets and liabilities: | ||
| Due from clients | (75,149) | (39,261) |
| Accounts receivable | 2,204 | (1,818) |
| Other current and noncurrent assets | 18,421 | (11,082) |
| Originations of mortgages held for sale | (55,529) | — |
| Proceeds from sale of mortgages held for sale | 50,479 | — |
| Accounts payable | (773) | (35) |
| Accrued liabilities | 1,831 | 9,033 |
| Due to clients | (19,211) | 1,463 |
| Payable to clearing broker | 75,219 | 39,659 |
| Lease liabilities | (1,906) | (1,801) |
| Other noncurrent liabilities | 64 | — |
| Net cash provided by operating activities | $69,992 | $77,405 |
| Investing activities | ||
| Purchases of property, software, and equipment | (1,253) | (632) |
| Net cash used in investing activities | $(1,253) | $(632) |
| Financing activities | ||
| Taxes paid related to net share settlement of RSUs | (10,353) | — |
| Net borrowings (payments) on short-term funding facilities | 4,935 | — |
| Proceeds from exercise of stock options, including early exercises | 6,970 | 5,121 |
| Proceeds from exercise of common stock warrants | 960 | — |
| Proceeds from issuance of common stock under ESPP | 3,176 | — |
| Repurchase of common stock | (60,099) | (238) |
| Net cash (used in) provided by financing activities | $(54,411) | $4,883 |
| Net (decrease) increase in cash and cash equivalents, cash segregated and on deposit for regulatory purposes, and restricted cash and cash equivalents | 14,328 | 81,656 |
| Cash and cash equivalents, cash segregated and on deposit for regulatory purposes, and restricted cash and cash equivalents at the beginning of the period | 453,790 | 154,553 |
| Cash and cash equivalents, cash segregated and on deposit for regulatory purposes, and restricted cash and cash equivalents at the end of the period | $468,118 | $236,209 |
| Supplemental disclosures of cash flow information | ||
| Cash (refunded) paid for income taxes | $296 | $2,828 |
| Cash paid for interest | $6,102 | $3,659 |
| Non-cash investing activities | ||
| Non-cash recognition of new lease | $— | $603 |
| Non-cash financing activities | ||
| Issuance of common stock upon cashless exercise of warrants | $449 | $— |
| The following presents cash and cash equivalents, cash segregated and on deposit for regulatory purposes, and restricted cash and cash equivalents | ||
| Cash and cash equivalents | $453,308 | $222,749 |
| Cash segregated and on deposit for regulatory purposes | 12,200 | 10,850 |
| Restricted cash and cash equivalents in other noncurrent assets | 2,610 | 2,610 |
| Total cash and cash equivalents, cash segregated and on deposit for regulatory purposes, and restricted cash and cash equivalents | $468,118 | $236,209 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.